About Taisho Holdings
Taisho Holdings is a publicly listed company based in Toshima (Japan) founded in 1912. Over-the-counter and prescription pharmaceutical drugs are manufactured. Taisho Holdings has completed 1 acquisition, including UPSA. Taisho Holdings offers products and services including Pabron Cold Medicine and Shinbiofermin S. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Taisho Pharmaceutical Co., Ltd.
Company details
Taisho Pharmaceutical was established in 1912 in Toshima City, Japan. Operations focus on the production of over-the-counter and prescription medications within the pharmaceutical sector. Manufacturing processes are conducted primarily in Japan, with distribution handled through domestic and select international channels. The company maintains a portfolio of drugs addressing various health needs, supported by research and development facilities in the region. Headquarters remain in Toshima City, overseeing global holdings.
- Headquarters Toshima, Japan
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website taisho-holdings.co.jp
- Social YouTube
- Legal Name Taisho Pharmaceutical Co., Ltd
- Investments & Acquisitions
Products & Services of Taisho Holdings
Taisho Holdings offers a comprehensive portfolio of products and services, including Pabron Cold Medicine and Shinbiofermin S.
Products are developed and distributed for the treatment of cold symptoms, with usage being guided by health professionals.
Medications are provided for intestinal health, with expiration and usage instructions being outlined for safe consumption.
Apps and channels of Taisho Holdings
its YouTube channel taishomovie has 30.4K subscribers and 30 videos.
Videos from Taisho Holdings
The most watched videos on Taisho Holdings's YouTube channel, taishomovie (30.4K subscribers). Click a video to play it here.
More on taishomovie.
Investments & Acquisitions by Taisho Holdings
Taisho Holdings has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include UPSA.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diversified pharmaceutical products are developed and distributed by UPSA. | upsa.com | 1935 | Dec 2018 | $1.6B |
Complete acquisition details for Taisho Holdings
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Taisho Holdings
3 dated milestones of Taisho Holdings across 106 years, from founding to its latest funding, stage changes and deals.
- Founded Taisho Holdings is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires UPSA.
Web traffic of Taisho Holdings
Websites that share an audience with Taisho Holdings (taisho-holdings.co.jp).
Websites whose visitors overlap most with Taisho Holdings. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biosimilar.jp | biosimilar.jp | 100% | #4,393,528 | – | |
| ayumi-pharma.com | 83% | 20.5K | #1,074,661 | View details | |
| ono-pharma.com | 83% | 112.3K | #536,517 | View details | |
| astellas.com | 83% | 170.7K | #288,207 | View details | |
aska-pharma.co.jp | aska-pharma.co.jp | 83% | #222,591 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Taisho Holdings
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Taisho Holdings
Taisho Holdings was founded in 1912.
Taisho Holdings is headquartered in Toshima, Japan. It is registered at Toshima, Tokyo, Japan.
Taisho Pharmaceutical was established in 1912 in Toshima City, Japan. Operations focus on the production of over-the-counter and prescription medications within the pharmaceutical sector. Manufacturing processes are conducted primarily in Japan, with distribution handled through domestic and select international channels. The company maintains a portfolio of drugs addressing various health needs, supported by research and development facilities in the region. Headquarters remain in Toshima City, overseeing global holdings.
Taisho Holdings offers Pabron Cold Medicine and Shinbiofermin S.
Taisho Holdings has made 1 acquisition, including UPSA.
Taisho Holdings operates through Taisho Pharmaceutical Co., Ltd.